Preamble
Recitals 76
Chapter I - SCOPE AND DEFINITIONS (Article 1-3) 3
Chapter II - APPROVAL OF ACTIVE SUBSTANCES (Article 4-11) 8
Chapter III - RENEWAL AND REVIEW OF APPROVAL OF AN ACTIVE SUBSTANCE (Article 12-16) 5
Chapter IV - GENERAL PRINCIPLES CONCERNING THE AUTHORISATION OF BIOCIDAL PRODUCTS (Article 17-24) 8
Chapter V - SIMPLIFIED AUTHORISATION PROCEDURE (Article 25-28) 4
Chapter VI - NATIONAL AUTHORISATIONS OF BIOCIDAL PRODUCTS (Article 29-31) 3
Chapter VII - MUTUAL RECOGNITION PROCEDURES (Article 32-40) 9
Chapter VIII - UNION AUTHORISATIONS OF BIOCIDAL PRODUCTS (Article 41-46) 6
Chapter IX - CANCELLATION, REVIEW AND AMENDMENT OF AUTHORISATIONS (Article 47-52) 6
Chapter X - PARALLEL TRADE (Article 53) 1
Chapter XI - TECHNICAL EQUIVALENCE (Article 54) 1
Chapter XII - DEROGATIONS (Article 55-57) 3
Chapter XIII - TREATED ARTICLES (Article 58) 1
Chapter XIV - DATA PROTECTION AND DATA-SHARING (Article 59-64) 6
Chapter XV - INFORMATION AND COMMUNICATION (Article 65-73) 9
Chapter XVI - THE AGENCY (Article 74-79) 6
Chapter XVII - FINAL PROVISIONS (Article 80-97) 18
Annexes 7

making available on the market

Uses as of 01/08/2017

Definitions over time (1)

17/07/2012 – 23/09/2013 Article 3, Regulation (EU) No 528/2012 Scope: Whole act

1. For the purposes of this Regulation, the following definitions shall apply:

‘making available on the market’ means any supply of a biocidal product or of a treated article for distribution or use in the course of a commercial activity, whether in return for payment or free of charge;

Each has its own scope, dates and uses. Open one to see when it applies.

No text uses this concept on 01/08/2017.